Vijaya Diagnostic CentreBOM:543350 -2.44%85 ROE % is 20.03% as of Mar. 2026, which is 4% below its 10-year median of 20.96. GuruFocus rates BOM:543350 with a GF Score™ of 85/100 and a GF Value™ of ₹1,184.07 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 202 Medical Diagnostics & Research companies, Vijaya Diagnostic Centre ranks better than 87.13% on this metric.
The historical rank and industry rank for Vijaya Diagnostic Centre's ROE % or its related term are showing as below:
BOM:543350'
s ROE % Range Over the Past 10 Years
Min: 16.71 Med: 20.96 Max: 26.67
Current: 19.79
During the past 8 years, Vijaya Diagnostic Centre's highest ROE % was 26.67%. The lowest was 16.71%. And the median was 20.96%.
BOM:543350's ROE % is ranked better than 87.13% of 202
companies
in the Medical Diagnostics & Research industry
Industry Median: -1.31
vs BOM:543350: 19.79
Vijaya Diagnostic Centre (BOM:543350) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Vijaya Diagnostic Centre's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vijaya Diagnostic Centre ROE % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Vijaya Diagnostic Centre's ROE % distribution charts can be found below:
* The bar in red indicates where Vijaya Diagnostic Centre's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Vijaya Diagnostic Centre (BOM:543350) has a ROE % of 20.03% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Vijaya Diagnostic Centre and its competitors. This is near median its historical median of 20.96. Over the past decade, Vijaya Diagnostic Centre's ROE % has ranged from 16.71 to 26.67. According to the industry distribution chart, Vijaya Diagnostic Centre ranks #26 out of 202 companies in the Medical Diagnostics & Research industry, placing it in the top 12.9%.
Is Vijaya Diagnostic Centre's ROE % too high?
Vijaya Diagnostic Centre's current ROE % of 20.03% is near median its 10-year median of 20.96. Over the past 10 years, this metric has ranged from a low of 16.71 to a high of 26.67. Based on the distribution chart, Vijaya Diagnostic Centre ranks #26 out of 202 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Vijaya Diagnostic Centre has a GF Score™ of 85/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vijaya Diagnostic Centre's ROE % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Vijaya Diagnostic Centre ranks #26 out of 202 companies for ROE %. This places Vijaya Diagnostic Centre in the top 13% of its industry — outperforming the majority of peers. Historically, Vijaya Diagnostic Centre's own ROE % has ranged from 16.71 to 26.67 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Medical Diagnostics & Research company?
A good ROE % depends on the Medical Diagnostics & Research industry context. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Vijaya Diagnostic Centre and its competitors. Vijaya Diagnostic Centre's current ROE % is 20.03%, which is near median its own 10-year median of 20.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vijaya Diagnostic Centre stock overvalued right now?
Based on GuruFocus' analysis, Vijaya Diagnostic Centre (BOM:543350) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹1,184.07, compared to a current price of ₹1,364.80 — trading 15.3% above its estimated fair value. The current ROE % is 20.03%, which is near median its 10-year median of 20.96. Vijaya Diagnostic Centre's overall GF Score™ is 85/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Vijaya Diagnostic Centre (BOM:543350), the current ROE % is 20.03% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vijaya Diagnostic Centre (BOM:543350) Overvalued in 2026?
Based on GuruFocus' analysis, Vijaya Diagnostic Centre stock appears to be overvalued.
The current stock price of ₹1,364.80 is trading 15.3% above its estimated GF Value™ of ₹1,184.07.
GuruFocus considers Vijaya Diagnostic Centre to be Modestly Overvalued.
Key valuation signals for BOM:543350:
ROE %: 20.03% (near median its 10-year median of 20.96)
GF Value™: ₹1,184.07 vs. price of ₹1,364.80 (15.3% above fair value)
No single metric tells the full story. See the BOM:543350 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vijaya Diagnostic Centre Ltd operates a diagnostic chain in Southern India. The company offers a one-stop solution for pathology and radiology testing services. It provides routine tests, specialized pathology tests, basic tests, and radiology tests. The company also offers a broad spectrum of customized health and wellness packages to its customers. The company's revenue comes from many diagnostic centers, where high-volume sales drive its earnings. The Company operates within India. The company's operations fall within a single business segment, which is Diagnostic Services.
85GF Score
Get the complete analysis for BOM:543350
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543350 has been successfully added to your 
